A
Alan E. Greenberg
Researcher at George Washington University
Publications - 146
Citations - 10096
Alan E. Greenberg is an academic researcher from George Washington University. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 51, co-authored 142 publications receiving 9734 citations. Previous affiliations of Alan E. Greenberg include Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial
Stefan Z. Wiktor,Ehounou R. Ekpini,John M. Karon,John N. Nkengasong,Chantal Maurice,Sibailly T Severin,Thierry H. Roels,Moïse K Kouassi,Eve M. Lackritz,Issa-Malick Coulibaly,Alan E. Greenberg +10 more
TL;DR: Short-course oral zidovudine was safe, well tolerated, and decreased mother-to-child transmission of HIV-1 at age 3 months, and substantial efforts will be needed to ensure successful widespread implementation of such a regimen.
Journal ArticleDOI
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
Scott D. Holmberg,Anne C. Moorman,John Williamson,Tony C. Tong,Douglas J. Ward,Kathy Wood,Alan E. Greenberg,Robert S. Janssen +7 more
TL;DR: It is suggested that, although infrequent, use of protease inhibitors is associated with increased risk of myocardial infarction in patients with HIV-1.
Journal ArticleDOI
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
Frank J. Palella,Maria Deloria-Knoll,Joan S. Chmiel,Anne C. Moorman,Kathleen C. Wood,Alan E. Greenberg,Scott D. Holmberg +6 more
TL;DR: This cohort study compares mortality rates among ambulatory HIV-infected patients who initiated ART and those who delayed ART in various CD4+ strata and defines HAART as the use of at least three drugs simultaneously.
Journal ArticleDOI
Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care.
Lytt I. Gardner,Lisa R. Metsch,Pamela Anderson-Mahoney,Anita M. Loughlin,Carlos del Rio,Steffanie A. Strathdee,Stephanie L. Sansom,Harvey A. Siegal,Alan E. Greenberg,Scott D. Holmberg +9 more
TL;DR: A brief intervention by a case manager was associated with a significantly higher rate of successful linkage to HIV care and the cost of such case management was estimated to be US$ 600–1200 per client.
Journal ArticleDOI
Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial
Stefan Z. Wiktor,Madeleine Sassan-Morokro,Alison D. Grant,L. Abouya,John M. Karon,Chantal Maurice,Gaston Djomand,A. Ackah,Kouao Domoua,Auguste Kadio,Achy Yapi,Patrice Combe,Odette Tossou,Thierry H. Roels,Eve M. Lackritz,D. Coulibaly,Kevin M. De Cock,Issa-Malick Coulibaly,Alan E. Greenberg +18 more
TL;DR: In HIV-1-infected patients with tuberculosis, daily co-trimoxazole prophylaxis was well tolerated and significantly decreased mortality and hospital admission rates.